Dr. Agarwal's Health Care Limited IPO
MainboardHospital
Listed On: Feb 4, 2025 at ₹ 402.0 (NSE)
₹ 14070 /35 Shares
Check Allotment29 Jan, 2025
Open Date31 Jan, 2025
Close Date01 Feb, 2025
Allotment Date04 Feb, 2025
Listing DateThe company has reserved 11,29,574 equity shares(1.5%) under shareholder quota. Eligible Shareholders of AEHL as of the RHP date(23rd Jan), would be eligible to apply for this Offer under the Shareholder's Reservation Portion.
Price Summary
Last Closing
497.40 (23.73%)52 Week High
515.0052 Week Low
327.00Last Update
3-Oct-2025 3:30 PMDr. Agarwal's Health Care IPO Issue Details
- Issue Price ₹382-402 per equity share
- Face Value ₹1 Per Equity Share Issue Size
- Total Size 7,53,04,970 shares(aggregating up to ₹3027.26 crore)
- Fresh Share 74,62,686 shares(aggregating up to ₹300 crore)
- Offer For Sale 6,78,42,284 shares(aggregating up to ₹2727.26 crore)
- Listing at BSE, NSE
- List Price 402.0 (NSE)
- Listing Date 2025-02-04
- Lead Manager Kotak Mahindra Capital Company Limited/nMorgan Stanley India Company Pvt Ltd
Jefferies India Private Limited
Motilal Oswal Investment Advisors Limited - Registrar Kfin Technologies Limited
Market Lot Size
Investors can bid for a minimum of 35 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 35 | ₹14,070 |
| Retail(max) | 14 | 490 | ₹1,96,980 |
| SHNI(min) | 15 | 525 | ₹2,11,050 |
| SHNI(max) | 71 | 2,485 | ₹9,98,970 |
| BHNI(min) | 72 | 2,520 | ₹10,13,040 |
Dr. Agarwal's Health Care IPO Reservation
Dr. Agarwal's Health Care IPO offers total 7,53,04,970 shares. Out of which 1,45,19,200 (19.28%) allocated to QIB, 1,08,89,400 (14.46%) allocated to NII,2,54,08,599 (33.74%) allocated to RII, 15,79,399 (2.1%) allocated to employees and 2,17,78,798 (28.92%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 2,17,78,798 (28.92%) | |
| QIB Shares Offered | 1,45,19,200 (19.28%) | |
| NII (HNI) Shares Offered | 1,08,89,400 (14.46%) | |
| bNII < ₹10L | 72,59,600 (9.64%) | |
| sNII < ₹10L | 36,29,800 (4.82%) | |
| Retail Shares Offered | 2,54,08,599 (33.74%) | |
| Employee Shares Offered | 15,79,399 (2.1%) | |
| Total Shares Offered | 7,53,04,970 (100%) |
Dr. Agarwal's Health Care IPO Details
Dr. Agarwal's Health Care IPO is a book-built issue of ₹3027.26 crores, The total issue size is ₹3027.26 crores. The IPO of Dr. Agarwal's Health Care is priced at ₹382-402 per equity share, which has a face value of ₹1 Per Equity Share each, IPO bidding starts from Jan 29, 2025 and ends on Jan 31, 2025. The allotment for Dr. Agarwal's Health Care IPO will be finalized on Feb 1, 2025. Dr. Agarwal's Health Care IPO will be listed on BSE, NSE, with a tentative listing date fixed as Feb 4, 2025. The company shall list its equity shares on the BSE, NSE. Kfin Technologies Limited is the registrar of the issue.
Retail investors can bid for a minimum of 35 shares, extendable to 14,070. S-HNIs will be able to bid for 525 shares at ₹2,11,050, while B-HNIs can also apply for a bid of 2,520 shares at ₹10,13,040. The book-running lead manager for the IPO is/are Kotak Mahindra Capital Company Limited/nMorgan Stanley India Company Pvt Ltd, Jefferies India Private Limited, Motilal Oswal Investment Advisors Limited.
The total issue ₹3027.26 crore, comprising a fresh issue of 74,62,686 shares ₹300 crore and having Offer for Sale (OFS) of 6,78,42,284 shares to mop up ₹2727.26 crore.
The Dr. Agarwal's Health Care IPO sets its price band at 382-402 for each share. A single application for Dr. Agarwal's Health Care Limited IPO must contain at least 35 shares. Sentiment investors need to invest a minimum of 35 through their retail account. For investors to prevent oversubscription issues, they should submit bids at the cutoff price, which estimates about ₹14,070 In order to participate in the sNII, investors must purchase at least 15 lots of 525 shares for ₹2,11,050, while the bNII requires 72 lots of 2,520 shares for an investment of ₹10,13,040.
Dr. Agarwal's Health Care IPO Subscription Analysis And Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 1,45,19,200 | 1,08,89,400 72,59,600 36,29,800 | 2,54,08,599 | 5,35,26,172 |
Day 1 29-01-25 05:00 PM | 0.00 x | 0.06 0.04 x 0.09 x | 0.11 x | 0.07 x |
Day 2 30-01-25 05:00 PM | 1.01 x | 0.12 0.08 x 0.20 x | 0.24 x | 0.42 x |
Day 3 31-01-25 05:00 PM | 4.64 x | 0.39 0.31 x 0.55 x | 0.41x/SH:0.51 x | 1.55 x |
Dr. Agarwal's Health Care Valuations
Dr. Agarwal's Health Care Company Financials
| 30-Sep-24 | 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|---|
| Assets | 3,393.41 | 2,752.82 | 1,825.17 | 1,026.13 |
| Revenue | 837.94 | 1,376.45 | 1,031.49 | 713.78 |
| Profit After Tax | 39.56 | 95.05 | 103.23 | 43.16 |
| Net Worth | 1,502.67 | 1,337.68 | 627.83 | 212.34 |
| Reserves & Surplus | 1,502.67 | 1,337.68 | 627.83 | 212.34 |
| Total Borrowing | 373.68 | 387.79 | 356.18 | 290.18 |
About Dr. Agarwal's Health Care Company
Established in 2010, Dr. Agarwal's Health Care Limited delivers a wide-ranging service of ophthalmic solutions, including cataract and refractive surgery, consultation and diagnosis, and non-surgical treatments, sales of optical goods, contact lenses, accessories, and pharmaceutical drugs related to eyes.
As of September 30, 2024, the company had 737 doctors treating patients in its facilities. During the same period, the company treated 2.13 million patients and performed 220,523 surgeries. For the six months ended September 30, 2024, they treated 1.15 million patients and performed 140,787 surgeries.
The Services offered by the company are:
Cataract surgeries; Provide cataract surgical services in its own facilities, which include small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments;
Refractive surgeries: These are surgeries used to correct the refractive errors of the eyes, helping a person decrease their dependence on eyeglasses or contact lenses. The major categories are LASIK, SMILE, implantable collamer lenses, and photorefractive keratectomy (PRK).
Other surgeries: Provide a number of other surgical interventions for ocular diseases, like surgical retinal interventions, corneal transplantation and pinhole pupilloplasty, oculoplasty and surgeries to treat glaucoma and pterygium.
By September 30, 2024, the company's Indian network includes 28 hubs (Tertiary Facilities, three COEs included) and 165 spokes (53 Primary and 112 Secondary Facilities).As on September 30, 2024, the Company has operations in India across 117 metro and non-metro cities in 14 states and four union territories through 193 Facilities.
Dr. Agarwal's Health Care - Promoter(s)
Dr. Amar Agarwal, Dr. Athiya Agarwal, Dr Adil Agarwal, Dr. Anosh Agarwal, Dr Ashvin Agarwal, Dr. Ashar Agarwal, Dr. Amar Agarwal Family Trust, Dr Adil Agarwal Family Trust, Dr. Anosh Agarwal Family Trust, Dr Ashvin Agarwal Family Trust, Dr. Ashar Agarwal Family Trust, Dr Agarwal’s Eye Institute and Dr Agarwal's Eye Institute Private Limited
Pre Issue Share Holding : 37.32%
Post Issue Share Holding : 32.50%
Dr. Agarwal's Health Care IPO - Issue Objectives
Repayment/prepayment, in part or full, of certain of the borrowings
General corporate purposes and unidentified inorganic acquisition.
Dr. Agarwal's Health Care IPO - Anchor Investors
Dr Agarwal's Health Care raises ₹875.50 crore from anchor investors.
Key foreign and domestic institutions, such as the Government of Singapore, Monetary Authority of Singapore, Government Pension Fund Global, and Fidelity, participated in the anchor round.
Other prominent investors were Invesco India Midcap Fund, The Nomura Trust, Ashoka Whiteoak MF, Motilal Oswal Small Cap Fund, Canara Robeco MF, VQ Fastercap Fund, The Prudential Assurance Co, HSBC Global Investment Fund, 360 One Equity Opportunity Fund, and Goldman Sachs (Singapore) PTE – ODI. Domestic names include LIC MF, Tata MF, Edelweiss MF, Axis Max Life, Aditya Birla Life, and Edelweiss Life Insurance as part of the anchor allocation.
Dr. Agarwal's Health Care IPO - Peers Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Dr. Agarwal's Health Care Limited | 3.14 | 3.13 | 50.53 | 130.44 | 6.21 | 8.04 | Consolidated |
| Apollo Hospitals Enterprise Ltd. | 62.5 | 62.5 | 481.93 | 107.11 | 62.5 | 13.2 | Consolidated |
| Max Healthcare Institute Limited | 10.89 | 10.84 | 86.54 | 95.88 | 12.58 | 9.52 | Consolidated |
| Fortis Healthcare Ltd. | 7.93 | 7.93 | 101.48 | 82.11 | 7.82 | 4.16 | Consolidated |
| Global Health Limited | 17.8 | 17.8 | 108.17 | 57.49 | 16.46 | 12.23 | Consolidated |
| Narayana Hrudayalaya Ltd | 38.86 | 38.86 | 141.98 | 33.14 | 27.37 | 5.33 | Consolidated |
| Krishna Institute of Medical Sciences Limited | 7.75 | 7.75 | 228.47 | 79.79 | 16.96 | 9.03 | Consolidated |
| Aster DM Healthcare Ltd | 3.6 | 3.6 | 71.62 | 136.07 | 3.63 | 5.76 | Consolidated |
| Rainbow Children's Medicare Limited | 21.38 | 21.38 | 124.03 | 67.9 | 17.24 | 10.46 | Consolidated |
Notes:
- Shares outstanding are as of September 30, 2024, apart from Narayana Hrudayalaya Limited, where shares outstanding are as of December 31, 2024.
- After the year ended March 31, 2024, the effect of stock split has been adjusted retrospectively presented for peers.
- The P/E ratio for the listed industry peers has been computed based on the closing market price of equity shares on BSE as of January 15, 2024, divided by the diluted earnings per share for the year ended March 31, 2024.
- Return on Net Worth (%) is calculated as profit for the year attributable to the owners of the company divided by the Net Worth at the end of the respective years.
- Net asset value (NAV) per equity share represents net worth divided by the weighted average number of shares as of March 31, 2024.
- Net worth means aggregate equity share capital, which includes instruments entirely equity in nature and other equity excluding legal reserve, capital redemption reserve, and other amalgamation reserves.
Contact Details
Dr. Agarwal's Health Care
1 st Floor, Buhari Towers, No.4, Moores Road, Off Greams Road, Near Asan Memorial School, Chennai 600 006
+91 44 4378 7777
Registrar Contact Details
Kfin Technologies Limited
04067162222, 04079611000
Dr. Agarwal's Health Care IPO - FAQs
Ans. Dr. Agarwal's Health Care Limited IPO is a Mainboard IPO. The issue is priced at ₹382-402 per equity share. The minimum order quantity is 35 Shares. The IPO opens on Jan 29, 2025, and closes on Jan 31, 2025. Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Ans. The Dr. Agarwal's Health Care Limited IPO opens on Jan 29, 2025 and closes on Jan 31, 2025.
Ans. You can track the real-time subscription numbers using the links below:
Ans. The size of Dr. Agarwal's Health Care Limited IPO is Total ₹3,027.76 Cr : #Fresh Issue : 74,62,686 shares(aggregating up to ₹300.00 Cr) + #OFS : 6,78,42,284 shares of ₹1(aggregating up to ₹2,727.26 Cr).
Ans. The IPO price band is set between ₹382-402 per equity share.
Ans. To apply for Dr. Agarwal's Health Care Limited IPO IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Dr. Agarwal's Health Care Limited IPO in the List of IPOs
- - Press Apply Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Dr. Agarwal's Health Care Limited IPO is Feb 1, 2025.
Ans. The Dr. Agarwal's Health Care Limited IPO will be listed on Feb 4, 2025.
Ans. Follow the steps to check the allotment status for Dr. Agarwal's Health Care Limited IPO here.
